AI in medical writing helps pharmaceutical teams draft, check and update documents faster. Writers use it for clinical study reports, regulatory submissions, protocols and standard operating procedures. A trained expert still reviews and approves every document. This guide explains where AI and GenAI fit in pharma documentation, which AI writing solutions exist for pharmaceutical companies, what to check before choosing one, and how to manage the risks. It also covers how teams can build the skills to use these tools well.
How Can AI be Used in the Pharmaceutical Industry?
AI is used across the drug lifecycle, from research to manufacturing and safety monitoring. It reads large datasets, finds patterns and drafts text, which gives teams more time for review and decisions.
Common uses include:
- Drug discovery: screening compounds and predicting targets
- Clinical trials: matching patients and selecting sites
- Manufacturing: predicting deviations and monitoring quality
- Pharmacovigilance: sorting and reviewing safety reports
- Documentation: drafting and checking scientific and regulatory documents
Each of these areas produces documents that must be written, checked and approved. Medical writing is one of the clearest places to apply AI, because the work is document-heavy and follows set rules.
What is AI in Medical Writing, and Where Does GenAI Fit?
Medical writing involves preparing scientific and regulatory documents that communicate clinical evidence and product information accurately and clearly. AI in medical writing means using software to support that work, from first drafts to final checks.
What Medical Writing Covers
In pharmaceutical companies, medical writers prepare clinical trial protocols, investigator brochures, clinical study reports, regulatory submissions, lay summaries and scientific publications. Each document follows a set structure and must match the underlying data. Small errors can delay reviews, so accuracy matters at every step.
How GenAI Differs From Earlier Automation Tools
Earlier tools followed fixed rules or templates. They filled in tables and formats but could not write new text. GenAI, short for generative AI, produces draft text from prompts, source data and templates. Teams use it to:
- Draft sections from approved source data
- Summarise literature and long documents
- Rewrite content for another audience, such as a lay summary
- Check terms, numbers and abbreviations for consistency
GenAI can produce errors that read confidently, so a trained writer must verify every output.
How Does AI in Regulatory Affairs Support Clinical Study Report Automation?
Clinical study reports summarise trial results for regulators and can run to hundreds of pages. AI in regulatory affairs supports this work by drafting from structured data and checking the result.
First Drafts of Clinical Study Reports and Regulatory Documents
AI can generate draft sections from structured clinical data, approved source documents and predefined templates. Novo Nordisk built a platform called NovoScribe for this purpose. According to Anthropic’s case study, clinical study documentation that once took more than ten weeks now reaches a reviewable first draft in about ten minutes. Results differ by company and process, so treat this as one example, not a benchmark.
A first draft is not a finished document. Writers must verify figures, interpretation and references against the source material. The draft then goes through the company’s medical, statistical, quality and regulatory review before approval.
Consistency Checks Across Documents
AI can compare numbers, terms and abbreviations across a protocol, a report and a summary. It flags mismatches, and a writer decides how to resolve each one.
Faster Review and Version Control
AI can summarise comment threads and show what changed between drafts. This can shorten review cycles. Approvals and signatures stay with named people.
Task | What AI handles | What a medical writer handles |
First draft | Drafts from data and templates | Checks accuracy and edits |
Consistency | Flags mismatched terms and numbers | Resolves each flag |
Review | Summarises comments and changes | Approves final content |
What Types of AI Medical Writing Solutions are Available?
Companies can choose from three types of AI medical writing solutions. The right choice depends on the document types, the compliance needs and the level of control required.
Pharma Regulatory AI Writing Tools
These tools are built for regulatory documents such as clinical study reports and submission sections. They often rely on structured authoring and libraries of approved text. They suit teams that produce the same document types again and again.
Pharma AI Writing Platforms
These platforms handle several document types in one system. They add workflow, templates, audit trails and user access control. They suit larger teams that manage many documents.
GenAI Tools with Pharma Controls
General GenAI assistants can support drafting, summarising and editing. Companies need rules on what data can be entered, and review steps, before using them on regulated content.
Type | Best for | Limits |
Regulatory AI writing tools | CSRs and submissions | Narrower document range |
AI writing platforms | Many document types | Setup and validation effort |
GenAI tools with controls | Drafting and summarising | Needs strict usage rules |
What Should You Look For in an AI Medical Writing Platform?
Check these before you choose:
- Evidence of GxP compliance for your intended use
- Computer system validation documentation
- Audit trails showing who changed what and when
- Electronic signature and access controls, including 21 CFR Part 11 where it applies
- Data privacy: where your data is stored and whether it is used to train the model
- Accuracy checks and traceability to source data
- Integration with your document and data systems
- Vendor support
Validation, audit trails and electronic signatures are related but separate requirements, so ask vendors about each one. Ask for a demo on your own document type, and ask how the tool handles source data and later updates.
Start with a pilot on one document type. Bring in an AI pharma consultant if you need help with validation or process design.
What are the Risks of GenAI in Medical Writing, and How Can Teams Reduce Them?
Regulatory expectations make governance essential when AI is used in pharmaceutical workflows. The European Medicines Agency’s reflection paper, first published in adopted form in September 2024, sets out considerations for AI across the medicinal product lifecycle. The US FDA’s January 2025 draft guidance proposes a risk-based framework for AI models that support regulatory decisions on drugs and biological products. It contains non-binding recommendations. The two documents differ in scope, but both call for assessing AI risk in context.
Errors can enter regulatory submissions if review and verification controls are inadequate. Each risk has a practical fix:
- Inaccurate or made-up content: verify every claim and citation against source data, and use approved text libraries
- Compliance gaps: use validated tools and record each review step
- Data security: use closed environments and keep confidential data out of public tools
- Over-reliance: define what AI drafts and what people approve, and train writers to spot errors
How Can Pharma Teams Build AI Skills For Medical and Regulatory Writing?
Choosing an AI tool is one part of adoption. Medical affairs and regulatory teams also need to know how to frame prompts, work with approved source material, identify unsupported claims, verify references and review AI-generated content.
Huksa provides expert-led corporate training to pharma companies. Its course, Artificial Intelligence for Medical and Regulatory Writing in Pharmaceuticals, is designed to help pharmaceutical professionals build these practical skills. The program covers:
- Prompt templates for clinical study reports, protocols, investigator brochures and lay summaries
- Data privacy, 21 CFR Part 11 considerations and audit-ready workflows
- Demonstrations of AI tools and human-in-the-loop quality checks
- Practical exercises based on pharmaceutical documentation scenarios
The aim is to help teams use AI more effectively while keeping the review discipline and accountability that pharmaceutical documentation requires.
Conclusion
AI in medical writing works best when it supports trained writers and reviewers. Use AI and GenAI for first drafts, consistency checks and summaries. Choose tools that meet GxP and data privacy needs, test them on one document type, and keep human approval in place. To prepare your team, explore Huksa’s course on AI for medical and regulatory writing, or contact Huksa to discuss corporate training for your organization.
FAQs
What Are the Best AI Solutions for Pharmaceutical Companies?
The best solution depends on the use case. Regulatory AI writing tools suit clinical study reports. AI writing platforms suit teams that handle many document types. GenAI tools with controls suit drafting and summarising. Check GxP compliance evidence, data privacy and audit trails first.
How Can AI be Used in the Pharmaceutical Industry?
AI supports drug discovery, clinical trials, manufacturing, pharmacovigilance and documentation. In medical writing, it drafts clinical study reports, summarises literature, checks consistency and prepares lay summaries, while trained experts review and approve the final content.
Which Pharma Company is Using AI?
Several do. Novo Nordisk uses its NovoScribe platform to draft clinical study documentation. Sanofi reports that most of its employees use an internal AI app every day. Vendors such as Aizon supply AI for pharma manufacturing.
Which AI is Best For Pharmacy?
The best AI depends on the task, such as drafting, literature review, quality checks or analytics. For regulated content, choose tools with audit trails, data controls and validation support, and keep expert review in place.
